Friday, July 03, 2020 11:57:47 AM
What? After all your pumping, telling everyone to hold for dollars, you now have doubts about RVVTF?
You never answered my question.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156601574
You never answered my question.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156601574
Regeneron's Arthritis Drug Fails COVID-19 Trial
https://www.fool.com/investing/2020/07/03/regenerons-rheumatoid-arthritis-drug-fails-covid-1.aspx
This is why RVV is tanking if Regeneron Arthritis drug failed I'm losing hope on this ticker. Hopefully the IND doesn't get delayed or this will really tank hard. I knew I should sold between .40-.50 always lock in profits and don't fall in love with a stock or it's story.
A Multicentre Trial of Bucillamine in the Treatment of Early Rheumatoid Arthritis (SNOW Study)
https://pubmed.ncbi.nlm.nih.gov/21188453/
This sucks!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
$RVVTF
Recent RVVTF News
- Revive Therapeutics Strengthens Bucillamine IP Portfolio with North American Patent Filings for Nerve Agent Exposure and Granted Canadian Patent for Infectious Diseases • ACCESS Newswire • 03/11/2026 11:30:00 AM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 12/15/2025 12:30:00 PM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 11/21/2025 05:07:49 PM
- Revive Therapeutics Announces Closing of Second Tranche of Private Placement • GlobeNewswire Inc. • 09/19/2025 09:00:28 PM
